# Merck Acquires Verona Pharma for $10 Billion

> ma · REPORTED · 2025-07-01

Merck made a $10 billion buyout offer for Verona Pharma, centered on its FDA-approved COPD drug Ohtuvayre, which represented the first new mechanism of action for the indication in more than two decades and had already generated $71.3 million in Q1 2025 sales.

- Company: Merck
- Sector: therapeutics
- Primary source: https://www.biospace.com/business/five-biggest-biopharma-takeovers-of-2025

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.